Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9662.
-
Enento Group Plc: Share Repurchase DisclosureEnento Group Plc reported its share repurchase activity for the week ending October 30, 2026.
-
Kamada to Announce Third Quarter 2026 Financial Results on November 9, 2026Kamada Ltd. has scheduled the release of its financial results for the third quarter and nine months ended September 30, 2026, for November 9, 2026.
-
Infineon Technologies AG Receives Goldman Sachs Voting Rights NotificationInfineon Technologies AG issued a regulatory announcement regarding a change in voting rights held by The Goldman Sachs Group, Inc.
-
Goldman Sachs Adjusts Generali Price TargetGoldman Sachs has lowered its price target for Assicurazioni Generali S.p.A. from 41.50 EUR to 41.30 EUR while maintaining a "Neutral" rating.
-
Safran Selected for Three French Nuclear Deterrence ProgramsSafran has been selected to provide its Hemispherical Resonating Gyroscope (HRG) technology for three French nuclear deterrence programs.
-
Glencore to adjust CEO compensation terms regarding potential takeoversGlencore is reportedly modifying CEO Gary Nagle's compensation package to protect his share awards in the event of a company takeover.
-
BrainsWay Announces Strategic Collaboration with Mindful Health SolutionsBrainsWay has entered into a strategic collaboration with Mindful Health Solutions to expand patient access to its Deep TMS and SWIFT treatment protocols.
-
Chloé Launches Festive 2026 Campaign Featuring Claudia SchifferRichemont's fashion house Chloé has unveiled its festive 2026 advertising campaign, starring supermodel Claudia Schiffer.
-
BASF SE Reports Share Buyback ProgressBASF SE announced the purchase of 355,128 shares between October 26 and October 30, 2026, as part of its ongoing share buyback program.
-
BNP Paribas Appointed for Share Repurchase ProgramBNP Paribas has been appointed to manage the on-market limb of a company's share repurchase program through January 2027.
-
Roche Receives FDA 510(k) Clearance for Cobas Eplex Respiratory Pathogen Panel 3Roche has obtained U.S. FDA 510(k) clearance for its new cobas eplex respiratory pathogen panel 3, a diagnostic tool designed to allow laboratories to customize respiratory testing.
-
Here's How Much $100 Invested In L3Harris Technologies 15 Years Ago Would Be Worth TodayL3Harris Technologies (NYSE:LHX) has outperformed the market over the past 15 years by 1.55% on an annualized basis producing an average annual return of 14.18%. Currently, L3Harris Technologies has a market
-
Inovio Stock Soars Following FDA Approval for Rare Respiratory Disease ImmunotherapyInovio stock surges after FDA accelerated approval of Voceryq, an immunotherapy reducing surgeries for adults with recurrent respiratory papillomatosis.
-
Nvidia, Costco and Nike join pushback against OKX–ICE tokenized stock plansNearly 70% of the companies initially picked for trading have opted out, while 19 firms including Apple, Tesla and Amazon have no disclosed objection as the 30-day response window nears its end.
-
Meta’s TextSeal2 improves detection of AI-generated text with new watermarking techniqueTextSeal2's advancements in AI text detection could set new industry standards, enhancing content authenticity and trust in digital media. The post Meta’s TextSeal2 improves detection of AI-generated text with new watermarking technique appeared first on Crypto Briefing .
-
Trade.xyz restores GitBook docs after unauthorized activity, warns users off linksThe incident highlights the critical need for robust security measures in digital platforms to protect user trust and prevent potential threats. The post Trade.xyz restores GitBook docs after unauthorized activity, warns users off links appeared first on Crypto Briefing .
-
USDC Treasury burns 100 million USDC on SolanaThe burn reflects Circle's active supply management, potentially boosting institutional trust in USDC's stability and compliance appeal. The post USDC Treasury burns 100 million USDC on Solana appeared first on Crypto Briefing .
-
Why Is Rivian Stock Surging on Monday?Rivian Automotive Inc. (NASDAQ: RIVN) stock is rising Monday following an upgrade from UBS analyst Joseph Spak and third-quarter financial results.
-
Anthropic swings to third quarter operating loss as compute costs surge ahead of IPOThe Claude developer generated $17 billion in quarterly revenue, but higher computing costs resulted in a $567 million operating loss.
-
Tilray Stock Rises As Cannabis Giant Raises EBITDA Outlook, Targets Restructuring Across CanadaTilray raises FY2027 EBITDA guidance to $70M-$75M and restructures Canadian cannabis operations, targeting $10M in annual savings.